Bio-Techne Shares Tick Higher as Activist Urges Strategic Review, Possible Sale
Shares of Bio-Techne Corporation rose in premarket trading after activist investor Ananym Capital Management disclosed a stake and called on the company's board to pursue a strategic review that could include selling the business. The activist highlighted underperformance versus peers, constrained organic growth and investments that have pressured …